Difference between revisions of "Norsworthy Kelly J., et al. Clinical Cancer Research (2019) cited as Ref 601 in DOI: 10.1038/s41392-020-0110-5 (Q9864)"
Jump to navigation
Jump to search
(Created claim: DOI Identifier (P138): 10.1158/1078-0432.CCR-19-0365, #quickstatements; #temporary_batch_1590000649558) |
(Created claim: PubMed ID (P140): 31064779, #quickstatements; #temporary_batch_1590001671040) |
||
| Property / PubMed ID | |||
| + | |||
| Property / PubMed ID: 31064779 / rank | |||
| + | Normal rank | ||
Revision as of 19:21, 20 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Norsworthy Kelly J., et al. Clinical Cancer Research (2019) cited as Ref 601 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Norsworthy Kelly J.
0 references
By Kunthel
0 references
Subramaniam Sriram
0 references
20
0 references
